Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) shares, rose in value on Wednesday, June 18, with the stock price up by 10.12% to the previous day’s close as strong demand from buyers drove the stock to $0.70.
Actively observing the price movement in the last trading, the stock closed the session at $0.63, falling within a range of $0.62 and $0.7359. The value of beta (5-year monthly) was 0.233. Referring to stock’s 52-week performance, its high was $7.11, and the low was $0.53. On the whole, IRWD has fluctuated by 14.20% over the past month.
With the market capitalization of Ironwood Pharmaceuticals Inc currently standing at about $113.08 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-07.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IRWD’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of IRWD currently trading nearly 10.66% and -5.00% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 50.84, while the 7-day volatility ratio is showing 8.61% which for the 30-day chart, stands at 9.86%. Furthermore, Ironwood Pharmaceuticals Inc (IRWD)’s beta value is 0.23, and its average true range (ATR) is 0.09.
A comparison of Ironwood Pharmaceuticals Inc (IRWD) with its peers suggests the former has fared considerably weaker in the market. IRWD showed an intraday change of 10.12% in last session, and over the past year, it shrunk by -88.01%%.
Data on historical trading for Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) indicates that the trading volumes over the past 10 days have averaged 3.21 and over the past 3 months, they’ve averaged 3.42 million. According to company’s latest data on outstanding shares, there are 161.81 million shares outstanding.
Nearly 3.73% of Ironwood Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 96.62% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.23 million shares as on 2025-05-30, resulting in a short ratio of 2.9. According to the data, the short interest in Ironwood Pharmaceuticals Inc (IRWD) stood at 772.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 8.8 million. The stock has fallen by -84.23% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IRWD stock heading into the next quarter.
